Prior studies have established that paraneoplastic thrombocytosis is driven in part by cancer cell-mediated release of interleukin-6 (IL-6), which stimulates the production of hepatic-derived and/or cancer-cell derived thrombopoietin to drive platelet overproduction [25,66,67]. The gene discussed is THPO; the disease is cancer.